Email bulletin archive Archive December 2018 Global trends in non-alcoholic fatty liver disease NAFLD can occur in lean people too Hepatitis C and the US opioid epidemic Resistance testing for hepatitis C Rwanda aims for hepatitis C elimination Egypt hepatitis C elimination Is this your copy of the infohep news bulletin? November 2018 News from The Liver Meeting Aspirin reduces liver cancer risk Sofosbuvir/ledipasvir for children aged three to six years Hepatitis C in rectal and nasal fluid Diabetes, stroke and cancer incidence fall after hepatitis C cure 8-week Maviret in cirrhosis NAFLD and cancer risk Experimental treatments for NASH and NAFLD Nivolumab for liver cancer HCV treatment in people who inject drugs Glecaprevir/pibrentasvir licensed to the Medicines Patent Pool Is this your copy of the infohep news bulletin? October 2018 Microelimination of HCV in people with co-infection Testing for hepatitis C What support do people with liver cirrhosis and their families need? What are the barriers to hepatitis C treatment in prisons? Low dead-space syringes associated with lower HCV prevalence Need for liver transplants due to hepatitis C drops in the United Kingdom News coverage of The Liver Meeting 2018 Is this your copy of the infohep news bulletin? September 2018 DAA treatment highly effective for people who use drugs HCV elimination in people who inject drugs Little progress towards universal testing of 'baby boomer' generation in United States Reinfection risk higher in recent drug users Screening pregnant women and infants for hepatitis C Psychological relief is the most important benefit of being cured of hepatitis C, say patients Safety and effectiveness of DAAs in older people Is this your copy of the infohep news bulletin? August 2018 End-stage liver disease deaths due to hepatitis C fall in the United Kingdom and Australia Supervised drug consumption rooms and hepatitis C testing and treatment Injecting drug users in South Africa: a high prevalence of HCV Transplants using organs from donors with HCV China Gilead patent Zepatier price cut Is this your copy of the infohep news bulletin? July 2018 World Hepatitis Day Treat all with hepatitis C, World Health Organization recommends Identifying people in need of hepatitis B treatment in Africa Hepatitis C treatment for people without liver damage Improved survival after liver transplant Access to HCV treatment for people with substance use or mental health issues Ramucirumab for liver cancer Is this your copy of the infohep news bulletin? June 2018 Hepatitis C testing and treatment in prisons Scotland and harm reduction Hepatitis C treatment and payer coverage in US Birth cohort testing in Canada Hepatitis C testing in community pharmacies Hepatitis C drugs to be discontinued Treatment for NASH 7th International Symposium on Hepatitis Care in Substance Users 2nd HEP-C Community Summit Is this your copy of the infohep news bulletin? May 2018 Quality of life after hepatitis C cure Portal hypertension after hepatitis C cure Cardiovascular disease risk and sustained virologic response Myrcludex: treatment for hepatitis delta Tenofovir alafenamide as treatment for hepatitis B Experimental treatment for hepatitis B Hepatitis C elimination in Georgia Treatment for hepatitis C in Africa Is this your copy of the infohep news bulletin? April 2018 News from the 2018 International Liver Congress, Paris Effectiveness of hepatitis C treatment EASL HCV treatment guidelines Liver cancer treatment guidelines Liver cancer treatment Liver cancer risk after DAA treatment Access to treatment Cost-effectiveness of early treatment for hepatitis C Shorter treatment courses for genotype 3 Is this your copy of the infohep news bulletin? March 2018 WHO progress report on access to treatment Hepatitis B: five countries account for more than half of all HBV infections Prevention of mother-to-child transmission of hepatitis B Hepatitis C elimination in prisoners Eliminating hepatitis C in England Successful HCV therapy reduces the risk of diabetes Next month: News from The International Liver Congress Is this your copy of the infohep news bulletin? February 2018 Harm reduction scale-up needed to reduce HCV prevalence among people who inject drugs Slowdown in new treatment uptake for hepatitis C starts in Australia Hepatitis C elimination in Georgia Improvement in fibrosis after hepatitis C cure Smoking in people with hepatitis C Is this your copy of the infohep news bulletin? January 2018 NHS England aims for hepatitis C elimination by 2025 Hepatitis B and secondary liver cancer Smoking and survival after liver cancer diagnosis Real world data on treatment success in people with HIV/HCV co-infection Is this your copy of the infohep news bulletin? 2022202120202019201820172016201520142013 Other pages in this section Latest news All the news Conference news Email bulletin archive